Molecular pathogenesis of spinocerebellar ataxias

AM Duenas, R Goold, P Giunti - Brain, 2006 - academic.oup.com
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of neurodegenerative
diseases, clinically and genetically heterogeneous, characterized by loss of balance and …

Diagnosis and treatment of Friedreich ataxia: a European perspective

JB Schulz, S Boesch, K Bürk, A Dürr, P Giunti… - Nature Reviews …, 2009 - nature.com
Friedreich ataxia is the most frequent hereditary ataxia, with an estimated prevalence of 3–4
cases per 100,000 individuals. This autosomal-recessive neurodegenerative disease is …

Clinical features of Friedreich's ataxia: classical and atypical phenotypes

…, W Nachbauer, C Mariotti, P Giunti - Journal of …, 2013 - Wiley Online Library
One hundred and fifty years since Nikolaus Friedreich's first description of the degenerative
ataxic syndrome which bears his name, his description remains at the core of the classical …

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

…, E Antoniou, H Drabkin, R Gemmill, P Giunti… - Nature …, 1997 - nature.com
The gene for spinocerebellar ataxia 7 (SCA7) has been mapped to chromosome 3p12–13.
By positional cloning, we have identified a new gene of unknown function containing a CAG …

[HTML][HTML] Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans

…, J Simon-Sanchez, NW Wood, P Giunti… - PLoS …, 2007 - journals.plos.org
We observed a severe autosomal recessive movement disorder in mice used within our
laboratory. We pursued a series of experiments to define the genetic lesion underlying this …

Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)

…, C Mariotti, KD Mathews, P Giunti… - Annals of …, 2021 - Wiley Online Library
Objective Friedreich ataxia (FA) is a progressive genetic neurodegenerative disorder with
no approved treatment. Omaveloxolone, an Nrf2 activator, improves mitochondrial function, …

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms

T Schmitz-Hubsch, M Coudert, P Bauer, P Giunti… - Neurology, 2008 - AAN Enterprises
Objective: To identify factors that determine disease severity and clinical phenotype of the
most common spinocerebellar ataxias (SCAs), we studied 526 patients with SCA1, SCA2, …

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study

H Jacobi, ST du Montcel, P Bauer, P Giunti… - The Lancet …, 2015 - thelancet.com
Background Spinocerebellar ataxias are dominantly inherited neurodegenerative diseases.
As potential treatments for these diseases are being developed, precise knowledge of their …

DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases

…, B Traynor, M Sweeney, N Wood, P Giunti… - Annals of …, 2016 - Wiley Online Library
Objective The polyglutamine diseases, including Huntington's disease (HD) and multiple
spinocerebellar ataxias (SCAs), are among the commonest hereditary neurodegenerative …

Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients

…, S Bonato, R Fancellu, P Giunti… - … : official journal of the …, 2006 - Wiley Online Library
To evaluate the efficacy of treatments in spinocerebellar ataxias (SCAs), appropriate clinical
scales are required. This study evaluated metric properties of the International Cooperative …